AzTrials
AzTrials

Kidney StoneNCT05265936

Is it Safe to Advance a Guidewire Through a Previously Placed Double j Stent?

A study testing Passing a guidewire through a double j stent and Double J stent removal and guidewire insertion in people with Kidney Stone and Ureter Obstruction, run by Ankara Training and Research Hospital at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In this prospective randomized controlled study, it is aimed to investigate the effects of guidewire advanced through a previously placed double j stent on postoperative complications, operation time and efficacy. Read more about this study

Who is it for?
Ages 18 to 90 years
What is being tested?
Passing a guidewire through a double j stent and Double J stent removal and guidewire insertion
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
88 participants
Where
1 siteTurkey (Türkiye)
Study dates
Mar 2022to Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Double J stent placed at least 2 weeks ago

Who cannot join

  • Active urinary tract infection

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ankara Training and Research Hospital

    Ankara, Altindag, 06230

Other trials in Turkey (Türkiye)

About this study

Official title: Is it Safe to Advance a Guidewire Through a Previously Deployed Double j Stent? A Prospective, Randomized, Controlled Study

In this prospective randomized controlled study, it is aimed to investigate the effects of guidewire advanced through a previously placed double j stent on postoperative complications, operation time and efficacy.

Being tested
Passing a guidewire through a double j stent, Double J stent removal and guidewire insertion
Keywords
double j stent, guidewire, infection
Medical subject headings
Kidney Calculi, Ureteral Obstruction, Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Passing a guidewire through a double j stentProcedure or surgery

    The previously placed double J stent is removed up to the urethral meatus with a cystoscope and forceps and kept fixed at the meatal level without further pulling. Then, after reaching the kidney by passing a guidewire through it, the double j stent is removed. Followed by the routine lithotripsy procedure.

  • Double J stent removal and guidewire insertionProcedure or surgery

    The double j stent is completely removed with the cystoscope and forceps, and the guidwire is inserted into the ureter by visualizing it with the cystoscope. Followed by the routine lithotripsy procedure.

Study groups in NCT05265936
Study groupRoleWhat they receive
Guidewire through DJ stentActive comparatorPatients who underwent lithotripsy after guidewire insertion through a previously placed double j stent.
Receives: Procedure: Passing a guidewire through a double j stent
DJ stent remove + guidewireSham comparatorPatients who underwent lithotripsy after double j stent removal and guidewire placement.
Receives: Procedure: Double J stent removal and guidewire insertion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of postoperative complication

    Rate of patients who had a postoperative complication

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2022
  2. Study startMar 2022 (estimated)
  3. Primary completionJun 2022 (estimated)
  4. Study completionJul 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
88 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05265936
Sponsor's protocol ID
DJG2022
Status last verified
Mar 2022
First submitted
22 Feb 2022
Last updated
4 Mar 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Leslie SW, Sajjad H. Double J Placement Methods Comparative Analysis. 2023 May 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK482453/

    PubMed 29494060

Questions about this trial

What is this clinical trial studying?

A study testing Passing a guidewire through a double j stent and Double J stent removal and guidewire insertion in people with Kidney Stone and Ureter Obstruction, run by Ankara Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ali Kaan Yildiz (+90 554 773 16 96, alikaanyildiz@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of postoperative complication (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05265936, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in